CORTISOL 11875116122

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2015-09-28 for CORTISOL 11875116122 manufactured by Roche Diagnostics.

Event Text Entries

[26882504]
Patient Sequence No: 1, Text Type: N, H10


[26882565] The customer reported that they received questionable results for a total of 28 patient saliva samples tested for cortisol. The samples were being tested as part of a lot to lot correlation on the e601 analyzer. Of the 28 samples, fourteen were found to have erroneous results that were reported outside of the laboratory. The results obtained with the current reagent lot number 178322 were high compared to results from the new reagent lot number 185380. The customer stated that they had noticed with increased frequency that controls were outside of range and patient results had been increasing. The results obtained with the current lot 178322 were reported outside of the laboratory. The results obtained with new lot 185380 were believed to be correct. The pathologist did not deem the difference in results to be clinically significant, so the results that had been reported outside of the laboratory were not corrected. The first patient sample resulted as 0. 396 ug/dl when tested with the current lot and resulted as 0. 241 ug/dl when tested with the new lot. The second patient sample resulted as 0. 353 ug/dl when tested with the current lot and resulted as 0. 203 ug/dl when tested with the new lot. The third patient sample resulted as 0. 286 ug/dl when tested with the current lot and resulted as 0. 176 ug/dl when tested with the new lot. The fourth patient sample resulted as 0. 864 ug/dl when tested with the current lot and resulted as 0. 546 ug/dl when tested with the new lot on (b)(6) 2015. This patient was a (b)(6). The fifth patient sample resulted as 0. 140 ug/dl when tested with the current lot and resulted as 0. 018 ug/dl when tested with the new lot on (b)(6) 2015. The sixth patient sample resulted as 0. 222 ug/dl when tested with the current lot and resulted as 0. 071 ug/dl when tested with the new lot on (b)(6) 2015. The seventh patient sample resulted as 0. 483 ug/dl when tested with the current lot and resulted as 0. 232 ug/dl when tested with the new lot on (b)(6) 2015. The eighth patient sample resulted as 63. 44 ug/dl when tested with the current lot and resulted as 39. 30 ug/dl when tested with the new lot on (b)(6) 2015. The ninth patient sample resulted as 0. 191 ug/dl when tested with the current lot and resulted as 0. 037 ug/dl when tested with the new lot on (b)(6) 2015. The tenth patient sample resulted as 0. 452 ug/dl when tested with the current lot and resulted as 0. 256 ug/dl when tested with the new lot on (b)(6) 2015. The eleventh patient sample resulted as 0. 297 ug/dl when tested with the current lot and resulted as 0. 183 ug/dl when tested with the new lot on (b)(6) 2015. The twelfth patient sample resulted as 0. 300 ug/dl when tested with the current lot and resulted as 0. 157 ug/dl when tested with the new lot on (b)(6) 2015. The thirteenth patient sample resulted as 0. 774 ug/dl when tested with the current lot and resulted as 0. 485 ug/dl when tested with the new lot on (b)(6) 2015. The fourteenth patient sample resulted as 0. 164 ug/dl when tested with the current lot and resulted as 0. 020 ug/dl when tested with the new lot on (b)(6) 2015. The patients were not adversely affected. The e601 analyzer serial number was (b)(4). The field service representative determined that the issue was caused by the older, current reagent lot number. The customer switched to the new lot number. Calibration and controls passed according to the customer's ranges. The field application specialist determined that the older, current lot was not recovering as expected. The new lot number was recovering within acceptable limits.
Patient Sequence No: 1, Text Type: D, B5


[31054199] A specific root cause could not be determined based on the provided information. Calibration effects are considered to contribute to the customer observed initial lot deviation. Both reagent lots showed higher than expected recovery for one of the calibrators. The quality control recovery trend was found to contradict the findings of the patient sample comparison. Internal method comparison data shows excellent agreement between the reagent lots in question.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2015-04226
MDR Report Key5107564
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2015-09-28
Date of Report2015-10-23
Date of Event2015-08-26
Date Mfgr Received2015-09-08
Date Added to Maude2015-09-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCORTISOL
Generic NameENZYME IMMUNOASSAY, CORTISOL, SALIVARY
Product CodeNHG
Date Received2015-09-28
Model NumberNA
Catalog Number11875116122
Lot Number17832201
ID NumberNA
Device Expiration Date2015-10-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2015-09-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.